OmniAb signs global ion channel collaboration deal with Eli Lilly, eyes up to $370 million in milestones

Reuters2026/08/17 10:02

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

OmniAb entered a global collaboration and license agreement with Eli Lilly for a new ion channel discovery program.
Deal includes an upfront payment. OmniAb can earn up to USD 370 million in research, development, commercial milestones.
Agreement also provides tiered royalties on global net sales.
Therapeutic target, modality were not disclosed.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. OmniAb Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202608170601BIZWIRE_USPR_____20260812_BW350809) on August 17, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

OmniAb signs global ion channel collaboration deal with Eli Lilly, eyes up to $370 million in milestones

You may also like

Crypto prices